The Role of Long Non-coding RNAs WRAP53 and UCA-1 as Potential Biomarkers in Diagnosis of Hepatocellular Carcinoma

TAURINE and HCC PATIENTS

NCT04193761 ·Status: COMPLETED ·Phase: NA

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

NCT03894917 ·Status: RECRUITING

Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound

NCT01208311 ·Status: COMPLETED

Diagnostic Accuracy of APAC, ASAP and GALAD Scores in Hepatocellular Carcinoma Among Cirrhotic Patients

NCT05738772 ·Status: UNKNOWN

Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer

NCT07145385 ·Status: NOT_YET_RECRUITING

Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population.

NCT02826005 ·Status: UNKNOWN ·Phase: NA

The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients

NCT07147335 ·Status: RECRUITING

The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC

NCT06042842 ·Status: UNKNOWN

Extracellular RNA Markers of Liver Disease and Cancer

NCT02908048 ·Status: TERMINATED

68Ga-FAPI PET/CT in Liver Fibrosis Patients

NCT04533828 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

The Assesment of MMP-1 Genotypes Polymorphism as a Risk Factor for HCC in Chronic HCV Patients With LC

NCT03722628 ·Status: UNKNOWN

Pangenomic Study During Alcoholic Cirrhosis

NCT01065233 ·Status: COMPLETED

Hepatic Steatosis and Chronic Hepatitis B Virus

NCT05678582 ·Status: COMPLETED

Clinical Study of MRD Recurrence Monitoring After Surgical Resection of Hepatocellular Carcinoma

NCT05458115 ·Status: UNKNOWN

Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer

NCT01034865 ·Status: COMPLETED

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

NCT05120557 ·Status: UNKNOWN ·Phase: NA

A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers

NCT02272504 ·Status: COMPLETED

The Utility of Breath Biopsy as a Screening Tool for HCC

NCT04326491 ·Status: COMPLETED

Non-invasive Diagnostic Model of Liver Fibrosis Associated With NAFLD and Prediction of Prognosis

NCT03842748 ·Status: UNKNOWN

Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian

NCT04081571 ·Status: UNKNOWN

MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients

NCT03227510 ·Status: UNKNOWN

The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt

NCT05047146 ·Status: COMPLETED

Screening for Liver Cancer With CT vs. Ultrasound in Patients With Advanced Liver Disease

NCT01350167 ·Status: UNKNOWN ·Phase: NA

Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma

NCT04414956 ·Status: RECRUITING ·Phase: NA

Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma

NCT03109457 ·Status: COMPLETED